Clinical trials
Nasopharyngeal Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 14 |
| Active, not recruiting | 10 |
| Terminated | 10 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| Baylor College of Medicine | 5 |
| M.D. Anderson Cancer Center | 4 |
| Emory University | 3 |
| Novartis Pharmaceuticals | 3 |
| Stanford University | 3 |
| Xencor, Inc. | 3 |
| Dana-Farber Cancer Institute | 2 |
| Incyte Corporation | 2 |
| NRG Oncology | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 59 |
| Squamous Cell Carcinoma of Head and Neck | 18 |
| Nasopharyngeal Neoplasms | 13 |
| Head and Neck Neoplasms | 12 |
| Laryngeal Neoplasms | 11 |
| Carcinoma | 10 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Carcinoma, Renal Cell | 9 |
| Carcinoma, Transitional Cell | 9 |
| Epstein-Barr Virus Infections | 9 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.